Cardiomyocyte tetrahydrobiopterin synthesis regulates fatty acid metabolism and susceptibility to ischaemia-reperfusion injury.
Sandy M ChuLisa C HeatherSurawee ChuaiphichaiThomas NicolBenjamin WrightMatthieu MiossecJennifer K BendallGillian DouglasMark J CrabtreeKeith M ChannonPublished in: Experimental physiology (2023)
(WT) littermates. Transcriptomic analyses and protein assays revealed downregulation of genes involved in fatty acid oxidation in cmGch1 KO hearts compared with WT, accompanied by increased triacylglycerol concentration within the myocardium. Deletion of cardiomyocyte BH4 did not alter basal cardiac function. However, the recovery of left ventricle function was improved in cmGch1 KO hearts when subjected to ex vivo ischaemia-reperfusion (IR) injury, with reduced infarct size compared to WT hearts. Metabolomic analyses of cardiac tissue after IR revealed that long-chain fatty acids were increased in cmGch1 KO hearts compared to WT, whereas at 5 min reperfusion (post-35 min ischaemia) fatty acid metabolite levels were higher in WT compared to cmGch1 KO hearts. These results indicate a new role for BH4 in cardiomyocyte fatty acid metabolism, such that reduction of cardiomyocyte BH4 confers a protective effect in response to cardiac IR injury. Manipulating cardiac metabolism via BH4 could play a therapeutic role in limiting IR injury.
Keyphrases
- fatty acid
- acute myocardial infarction
- cerebral ischemia
- left ventricular
- angiotensin ii
- single cell
- high glucose
- acute ischemic stroke
- cell proliferation
- percutaneous coronary intervention
- rna seq
- hydrogen peroxide
- binding protein
- pulmonary hypertension
- coronary artery disease
- signaling pathway
- small molecule
- nitric oxide
- pulmonary arterial hypertension
- endothelial cells
- brain injury